Gregory H Bennett1, Laurie Carpenter2, Wei Hao2, Peter Song2, Joel Steinberg3, Alan P Baptist4. 1. Division of Allergy and Clinical Immunology, University of Michigan Health System, Ann Arbor, Michigan. Electronic address: grbennet@med.umich.edu. 2. University of Michigan School of Public Health, Ann Arbor, Michigan. 3. Department of Internal Medicine, Wayne State University, Detroit, Michigan. 4. Division of Allergy and Clinical Immunology, University of Michigan Health System, Ann Arbor, Michigan; University of Michigan School of Public Health, Ann Arbor, Michigan.
Abstract
BACKGROUND: Asthma in older adults is associated with increased morbidity and mortality compared with asthma in younger patients. Fixed airflow obstruction (FAO) is associated with decreased survival in younger patients, but its significance remains unclear in older adults with asthma. OBJECTIVE: To identify risk factors and outcomes related to FAO in older adults with asthma. METHODS: Subjects older than 55 years with a physician diagnosis of persistent asthma were evaluated. Collected data included participant demographic information, medications, asthma exacerbations, Asthma Control Test (ACT) score, Asthma Quality of Life (AQLQ) score, comorbidities, spirometry, atopic status, and fractional exhaled nitric oxide. Clinical characteristics and outcomes associated with FAO (defined as post-bronchodilator ratio of forced expiratory volume in 1 second to forced vital capacity ≤70%) were assessed. RESULTS: A total of 186 participants were analyzed (48 men and 138 women, mean age 66 years). FAO was demonstrated in 30% of participants. Using regression analysis, predictors of FAO included advanced age, African American race, male sex, and longer duration of asthma. In outcomes analysis, FAO was associated with worsened ACT and AQLQ scores; however, after controlling for confounding factors, logistic regression showed no association. No significant association was found between FAO and exacerbations, fractional exhaled nitric oxide, atopy, rhinitis, education level, depression, smoking, or body mass index. CONCLUSION: Risk factors associated with FAO in older adults with asthma include advanced age, African American race, increased asthma duration, and male sex. Unlike younger patients, FAO is not independently associated with worsened asthma control, quality of life, or exacerbations in older patients with asthma. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01979055.
BACKGROUND:Asthma in older adults is associated with increased morbidity and mortality compared with asthma in younger patients. Fixed airflow obstruction (FAO) is associated with decreased survival in younger patients, but its significance remains unclear in older adults with asthma. OBJECTIVE: To identify risk factors and outcomes related to FAO in older adults with asthma. METHODS: Subjects older than 55 years with a physician diagnosis of persistent asthma were evaluated. Collected data included participant demographic information, medications, asthma exacerbations, Asthma Control Test (ACT) score, Asthma Quality of Life (AQLQ) score, comorbidities, spirometry, atopic status, and fractional exhaled nitric oxide. Clinical characteristics and outcomes associated with FAO (defined as post-bronchodilator ratio of forced expiratory volume in 1 second to forced vital capacity ≤70%) were assessed. RESULTS: A total of 186 participants were analyzed (48 men and 138 women, mean age 66 years). FAO was demonstrated in 30% of participants. Using regression analysis, predictors of FAO included advanced age, African American race, male sex, and longer duration of asthma. In outcomes analysis, FAO was associated with worsened ACT and AQLQ scores; however, after controlling for confounding factors, logistic regression showed no association. No significant association was found between FAO and exacerbations, fractional exhaled nitric oxide, atopy, rhinitis, education level, depression, smoking, or body mass index. CONCLUSION: Risk factors associated with FAO in older adults with asthma include advanced age, African American race, increased asthma duration, and male sex. Unlike younger patients, FAO is not independently associated with worsened asthma control, quality of life, or exacerbations in older patients with asthma. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01979055.
Authors: A Sonia Buist; William M Vollmer; Sandra R Wilson; E Ann Frazier; Arthur D Hayward Journal: Am J Respir Crit Care Med Date: 2006-08-24 Impact factor: 21.405
Authors: Marta Kaminska; Susan Foley; Karim Maghni; Claudine Storness-Bliss; Harvey Coxson; Heberto Ghezzo; Catherine Lemière; Ronald Olivenstein; Pierre Ernst; Qutayba Hamid; James Martin Journal: J Allergy Clin Immunol Date: 2009-05-29 Impact factor: 10.793
Authors: June H Lee; Tmirah Haselkorn; Larry Borish; Lawrence Rasouliyan; Bradley E Chipps; Sally E Wenzel Journal: Chest Date: 2007-12 Impact factor: 9.410
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Taehoon Lee; Yoon Su Lee; Yun-Jeong Bae; Tae-Bum Kim; Seon Ok Kim; Sang-Heon Cho; Hee-Bom Moon; You Sook Cho Journal: Respir Res Date: 2011-01-03
Authors: Alan P Baptist; Wei Hao; Peter X Song; Laurie Carpenter; Joel Steinberg; Lavoisier J Cardozo Journal: Ann Allergy Asthma Immunol Date: 2019-12-23 Impact factor: 6.347
Authors: Alberto Papi; Dave Singh; J Christian Virchow; G Walter Canonica; Andrea Vele; George Georges Journal: Clin Transl Allergy Date: 2022-04-17 Impact factor: 5.657